138 related articles for article (PubMed ID: 12931726)
1. [Targeted against T-cells: immunomodulators in psoriasis].
Mader U
Dtsch Med Wochenschr; 2003 Aug; 128(31-32):1640. PubMed ID: 12931726
[No Abstract] [Full Text] [Related]
2. Immunopathogenesis and immunotherapy of psoriasis.
Griffiths TW; Griffiths CE; Voorhees JJ
Dermatol Clin; 1995 Oct; 13(4):739-49. PubMed ID: 8785879
[TBL] [Abstract][Full Text] [Related]
3. [The use of bacterial preparations in the treatment of asthma in children].
Neguţ E; Peligrad I; Dincă L; Szegli G
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1989; 34(3):277-83. PubMed ID: 2694303
[No Abstract] [Full Text] [Related]
4. New treatments for psoriasis.
Granstein RD
N Engl J Med; 2001 Jul; 345(4):284-7. PubMed ID: 11474669
[No Abstract] [Full Text] [Related]
5. Incorporating biologics into the treatment of psoriasis.
Lui H; Langley R; Poulin Y; Gupta AK; Carey W; Guenther L; Searles G; Toole J; Lynde C; Gulliver W; Barber K
J Cutan Med Surg; 2004 Aug; 8 Suppl():8-13. PubMed ID: 15655584
[No Abstract] [Full Text] [Related]
6. [New therapy option for problem patients. What is the value of "biologics" in psoriasis?].
Boehncke WH
MMW Fortschr Med; 2004 Nov; 146(46):45. PubMed ID: 15600044
[No Abstract] [Full Text] [Related]
7. From laboratory to clinic: rationale for biologic therapy.
Mehlis S; Gordon KB
Dermatol Clin; 2004 Oct; 22(4):371-7, vii-viii. PubMed ID: 15450333
[TBL] [Abstract][Full Text] [Related]
8. [Immunotherapy against psoriasis].
Gjersvik PJ
Tidsskr Nor Laegeforen; 2003 Apr; 123(8):1049. PubMed ID: 12760217
[No Abstract] [Full Text] [Related]
9. [Use of biologicals in psoriasis].
Friedrich M; Philipp S; Sabat R; Asadullah K; Sterry W
Z Rheumatol; 2003 Oct; 62(5):439-49. PubMed ID: 14579031
[TBL] [Abstract][Full Text] [Related]
10. Smart weapons.
Kraco K
Minn Med; 2004 May; 87(5):28-32. PubMed ID: 15191065
[No Abstract] [Full Text] [Related]
11. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
[TBL] [Abstract][Full Text] [Related]
12. [Psoriasis: pathogenesis and treatment].
Heenen M
Rev Med Brux; 2003 Jun; 24(3):139-47. PubMed ID: 12891880
[TBL] [Abstract][Full Text] [Related]
13. The effect of therapy with selected immunomodulators on interleukin-2 production by peripheral blood lymphocytes.
Moniuszko T; Rogalewska A; Chyrek-Borowska S
Pneumonol Alergol Pol; 1992; 60 Suppl 2():120-1. PubMed ID: 1284817
[No Abstract] [Full Text] [Related]
14. Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences.
Kormeili T; Lowe NJ; Yamauchi PS
Br J Dermatol; 2004 Jul; 151(1):3-15. PubMed ID: 15270867
[TBL] [Abstract][Full Text] [Related]
15. [The basic methods of treating psoriasis patients].
Skripkin IuK; Kalamkarian AA; Mandel' ASh; Timoshin GG
Vestn Dermatol Venerol; 1987; (7):22-7. PubMed ID: 3314235
[No Abstract] [Full Text] [Related]
16. Thymostimulin in treatment of psoriasis.
Pedragosa R; Vidal J
Arch Dermatol; 1986 Jun; 122(6):624. PubMed ID: 3717970
[No Abstract] [Full Text] [Related]
17. Immunopathogenesis and immunocorrection of psoriasis.
Rubins AY; Wekhsler HM; Merson AG; Guseva LN; Grant HY; Poluektova LE; Gipsh NM; Rubine GY
Acta Derm Venereol Suppl (Stockh); 1989; 146():13-5. PubMed ID: 2532842
[No Abstract] [Full Text] [Related]
18. [In vitro system for determining the use of immunocorrective agents in patients with disseminated psoriasis].
Vasil'eva LL; Amirova IA
Vestn Dermatol Venerol; 1984 Oct; (10):6-8. PubMed ID: 6334943
[No Abstract] [Full Text] [Related]
19. Novel immunotherapies for psoriasis.
Asadullah K; Volk HD; Sterry W
Trends Immunol; 2002 Jan; 23(1):47-53. PubMed ID: 11801454
[TBL] [Abstract][Full Text] [Related]
20. [Effect of decaris and apilac on the immune system of persons frequently ill with tonsillitis and their susceptibility to the causative agents of this disease].
Liashenko IuI; Kubenskiĭ EN
Vestn Otorinolaringol; 1982; (1):60-4. PubMed ID: 6977908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
